152 related articles for article (PubMed ID: 12555693)
1. Uncovering the complexities of retroviral ribonuclease H reveals its potential as a therapeutic target.
Klarmann GJ; Hawkins ME; Le Grice SF
AIDS Rev; 2002; 4(4):183-94. PubMed ID: 12555693
[TBL] [Abstract][Full Text] [Related]
2. 6-[1-(4-Fluorophenyl)methyl-1H-pyrrol-2-yl)]-2,4-dioxo-5-hexenoic acid ethyl ester a novel diketo acid derivative which selectively inhibits the HIV-1 viral replication in cell culture and the ribonuclease H activity in vitro.
Tramontano E; Esposito F; Badas R; Di Santo R; Costi R; La Colla P
Antiviral Res; 2005 Feb; 65(2):117-24. PubMed ID: 15708638
[TBL] [Abstract][Full Text] [Related]
3. Drug targeting of HIV-1 RNA.DNA hybrid structures: thermodynamics of recognition and impact on reverse transcriptase-mediated ribonuclease H activity and viral replication.
Li TK; Barbieri CM; Lin HC; Rabson AB; Yang G; Fan Y; Gaffney BL; Jones RA; Pilch DS
Biochemistry; 2004 Aug; 43(30):9732-42. PubMed ID: 15274628
[TBL] [Abstract][Full Text] [Related]
4. The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is affected by the thumb subdomain of the small protein subunits.
Sevilya Z; Loya S; Hughes SH; Hizi A
J Mol Biol; 2001 Aug; 311(5):957-71. PubMed ID: 11531332
[TBL] [Abstract][Full Text] [Related]
5. The involvement of HIV-1 RNAse H in resistance to nucleoside analogues.
Roquebert B; Marcelin AG
J Antimicrob Chemother; 2008 May; 61(5):973-5. PubMed ID: 18325896
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones.
Budihas SR; Gorshkova I; Gaidamakov S; Wamiru A; Bona MK; Parniak MA; Crouch RJ; McMahon JB; Beutler JA; Le Grice SF
Nucleic Acids Res; 2005; 33(4):1249-56. PubMed ID: 15741178
[TBL] [Abstract][Full Text] [Related]
7. Novel HIV-1 reverse transcriptase inhibitors.
Jochmans D
Virus Res; 2008 Jun; 134(1-2):171-85. PubMed ID: 18308412
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human immunodeficiency virus type 1 reverse transcriptase, RNase H, and integrase activities by hydroxytropolones.
Didierjean J; Isel C; Querré F; Mouscadet JF; Aubertin AM; Valnot JY; Piettre SR; Marquet R
Antimicrob Agents Chemother; 2005 Dec; 49(12):4884-94. PubMed ID: 16304149
[TBL] [Abstract][Full Text] [Related]
9. 'Binding, bending and bonding': polypurine tract-primed initiation of plus-strand DNA synthesis in human immunodeficiency virus.
Rausch JW; Le Grice SF
Int J Biochem Cell Biol; 2004 Sep; 36(9):1752-66. PubMed ID: 15183342
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and RDDP functions.
Corona A; Onnis V; Deplano A; Bianco G; Demurtas M; Distinto S; Cheng YC; Alcaro S; Esposito F; Tramontano E
Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28859311
[TBL] [Abstract][Full Text] [Related]
11. Targeting the retroviral ribonuclease H by rational drug design.
Moelling K
AIDS; 2012 Oct; 26(16):1983-93. PubMed ID: 22555171
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of HIV-1 reverse transcriptase (HIV-1 RT) RNase H by small RNA hairpins and dumbbells.
Hannoush RN; Carriero S; Min KL; Damha MJ
Chembiochem; 2004 Apr; 5(4):527-33. PubMed ID: 15185377
[TBL] [Abstract][Full Text] [Related]
13. Multi-target activity of Hemidesmus indicus decoction against innovative HIV-1 drug targets and characterization of Lupeol mode of action.
Esposito F; Mandrone M; Del Vecchio C; Carli I; Distinto S; Corona A; Lianza M; Piano D; Tacchini M; Maccioni E; Cottiglia F; Saccon E; Poli F; Parolin C; Tramontano E
Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28637198
[TBL] [Abstract][Full Text] [Related]
14. Past and future. Current drugs targeting HIV-1 integrase and reverse transcriptase-associated ribonuclease H activity: single and dual active site inhibitors.
Esposito F; Tramontano E
Antivir Chem Chemother; 2014 Jan; 23(4):129-44. PubMed ID: 24150519
[TBL] [Abstract][Full Text] [Related]
15. Mg2+ dependency of HIV-1 reverse transcription, inhibition by nucleoside analogues and resistance.
Goldschmidt V; Didierjean J; Ehresmann B; Ehresmann C; Isel C; Marquet R
Nucleic Acids Res; 2006; 34(1):42-52. PubMed ID: 16394022
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 integrase and RNase H activities as therapeutic targets.
Andréola ML; De Soultrait VR; Fournier M; Parissi V; Desjobert C; Litvak S
Expert Opin Ther Targets; 2002 Aug; 6(4):433-46. PubMed ID: 12223059
[TBL] [Abstract][Full Text] [Related]
17. A fluorescence-based high-throughput screening assay for inhibitors of human immunodeficiency virus-1 reverse transcriptase-associated ribonuclease H activity.
Parniak MA; Min KL; Budihas SR; Le Grice SF; Beutler JA
Anal Biochem; 2003 Nov; 322(1):33-9. PubMed ID: 14705777
[TBL] [Abstract][Full Text] [Related]
18. Substrate-dependent inhibition or stimulation of HIV RNase H activity by non-nucleoside reverse transcriptase inhibitors (NNRTIs).
Hang JQ; Li Y; Yang Y; Cammack N; Mirzadegan T; Klumpp K
Biochem Biophys Res Commun; 2007 Jan; 352(2):341-50. PubMed ID: 17113568
[TBL] [Abstract][Full Text] [Related]
19. Relationship between mutations in HIV-1 RNase H domain and nucleoside reverse transcriptase inhibitors resistance mutations in naïve and pre-treated HIV infected patients.
Roquebert B; Wirden M; Simon A; Deval J; Katlama C; Calvez V; Marcelin AG
J Med Virol; 2007 Mar; 79(3):207-11. PubMed ID: 17245724
[TBL] [Abstract][Full Text] [Related]
20. Relationship between enzyme activity and dimeric structure of recombinant HIV-1 reverse transcriptase.
Tachedjian G; Radzio J; Sluis-Cremer N
Proteins; 2005 Jul; 60(1):5-13. PubMed ID: 15852304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
